Omeprazol Cinfamed (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Cinfamed, is a Proton Pump Inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Cinfamed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Cinfamed is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory therapy.

Omeprazol Cinfamed may cause a range of adverse reactions. Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain or flatulence: mild discomfort. - Constipation: occasional bowel habit change. - Dry mouth: reduced salivary flow. Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, airway compromise. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, arrhythmia risk. - Bone fracture risk with long‑term use: especially in the hip, wrist or spine.

When prescribing Omeprazol Cinfamed, clinicians should consider several safety aspects: - Assess renal and hepatic function: dose adjustment may be required in impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for signs of infection: especially gastrointestinal. - Evaluate long‑term use: consider bone health and nutrient absorption. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered drugs. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir or other protease inhibitors: markedly decreased antiviral exposure. - Methotrexate (high dose): increased toxicity risk. Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Phenytoin: possible reduction in serum levels. - Digoxin: modest increase in concentration requiring observation.